Stabilization of fenofibrate in low molecular weight hydroxypropylcellulose matrices produced by hot-melt extrusion

References

• Merisko-Liversidge E (2002) Nanocrystals: resolving pharma­ceutical formulation issues associated with poorly water-soluble compounds.. In: Marty, JJ. (Ed.), Particles. Orlando: Marcel Dekker.
   Google Scholar
• Crowley MM, Zhang F, Repka MA, Thumma S, Upadhye SB, Battu SK et al. (2007). Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm, 33:909–926.
   PubMed Web of Science ®Google Scholar
• Fukuda M, Miller DA, Peppas NA, McGinity JW. (2008). Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion. Int J Pharm, 350:188–196.
   PubMed Web of Science ®Google Scholar
• Hülsmann S, Backensfeld T, Keitel S, Bodmeier R. (2000). Melt extrusion–an alternative method for enhancing the dissolution rate of 17 beta-estradiol hemihydrate. Eur J Pharm Biopharm, 49:237–242.
   PubMed Web of Science ®Google Scholar
• Lakshman JP, Cao Y, Kowalski J, Serajuddin AT. (2008). Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug. Mol Pharm, 5:994–1002.
   PubMed Web of Science ®Google Scholar
• Miller DA, McConville JT, Yang W, Williams RO 3rd, McGinity JW. (2007). Hot-melt extrusion for enhanced delivery of drug particles. J Pharm Sci, 96:361–376.
   PubMed Web of Science ®Google Scholar
• Nakamichi K, Nakano T, Yasuura H, Izumi S, Kawashima Y. (2002). The role of the kneading paddle and the effects of screw revolution speed and water content on the preparation of solid dispersions using a twin-screw extruder. Int J Pharm, 241:203–211.
   PubMed Web of Science ®Google Scholar
• Perissutti B, Newton JM, Podczeck F, Rubessa F. (2002). Preparation of extruded carbamazepine and PEG 4000 as a potential rapid release dosage form. Eur J Pharm Biopharm, 53:125–132.
   PubMed Web of Science ®Google Scholar
• Prodduturi S, Urman KL, Otaigbe JU, Repka MA. (2007). Stabilization of hot-melt extrusion formulations containing solid solutions using polymer blends. AAPS PharmSciTech, 8: Article 50.
   PubMed Web of Science ®Google Scholar
• Repka MA, Battu SK, Upadhye SB, Thumma S, Crowley MM, Zhang F et al. (2007). Pharmaceutical applications of hot-melt extrusion: part II. Drug Dev Ind Pharm, 33:1043–1057.
   PubMed Web of Science ®Google Scholar
• Repka MA, Majumdar S, Kumar Battu S, Srirangam R, Upadhye SB. (2008). Applications of hot-melt extrusion for drug delivery. Expert Opin Drug Deliv, 5:1357–1376.
   PubMed Web of Science ®Google Scholar
• Six K, Berghmans H, Leuner C, Dressman J, Van Werde K, Mullens J et al. (2003). Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion, Part II. Pharm Res, 20:1047–1054.
   PubMed Web of Science ®Google Scholar
• Sun Y, Rui Y, Wenliang Z, Tang X. (2008). Nimodipine semi-solid capsules containing solid dispersion for improving dissolution. Int J Pharm, 359:144–149.
   PubMed Web of Science ®Google Scholar
• Verreck G, Six K, Van den Mooter G, Baert L, Peeters J, Brewster ME. (2003). Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion–Part I. Int J Pharm, 251:165–174.
   PubMed Web of Science ®Google Scholar
• Ranzani LS, Font J, Galimany F, Santanach A, Gomez-Gomar AM, Casadevall G et al. (2011). Enhanced in vivo absorption of CB-1 antagonist in rats via solid solutions prepared by hot-melt extrusion. Drug Dev Ind Pharm, 37:694–701.
   PubMed Web of Science ®Google Scholar
• Mcginity JW, Repka MA, Koleng JJ, Zhang F. (2006) Hot-melt extrusion technology. IN Swarbrick J. (Ed.) Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker, Inc.
   Google Scholar
• Lulla A, Malhotra G. (2009) Solid pharmaceutical dosage form. In: Organization, WIP. (ed.) A61K 9/14(2006.01), A61K 31/167(2006.01), A61K 9/20(2006.01) ed.
   Google Scholar
• Buch P, Holm P, Thomassen JQ, Scherer D, Branscheid R, Kolb U et al. (2010). IVIVC for fenofibrate immediate release tablets using solubility and permeability as in vitro predictors for pharmacokinetics. J Pharm Sci, 99:4427–4436.
   PubMed Web of Science ®Google Scholar
• Vogt M, Kunath K, Dressman JB. (2008). Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations. Eur J Pharm Biopharm, 68:283–288.
   PubMed Web of Science ®Google Scholar
• de Waard H, Hinrichs WL, Frijlink HW. (2008). A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying. J Control Release, 128:179–183.
   PubMed Web of Science ®Google Scholar
• Go´Rniak A, Wojakowska A, Karolewicz BZ, Pluta J. (2011) Phase diagram and dissolution studies of the fenofibrate–acetylsalicylic acid system. J Therm Anal Calorim, 104:1195–1200.
   Web of Science ®Google Scholar
• Sanganwar GP, Gupta RB. (2008). Dissolution-rate enhancement of fenofibrate by adsorption onto silica using supercritical carbon dioxide. Int J Pharm, 360:213–218.
   PubMed Web of Science ®Google Scholar
• Zhou D, Zhang GG, Law D, Grant DJ, Schmitt EA. (2002). Physical stability of amorphous pharmaceuticals: importance of configurational thermodynamic quantities and molecular mobility. J Pharm Sci, 91:1863–1872.
   PubMed Web of Science ®Google Scholar
• Khougaz K, Clas SD. (2000). Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers. J Pharm Sci, 89:1325–1334.
   PubMed Web of Science ®Google Scholar
• Kim JH, Choi HK. (2002). Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix. Int J Pharm, 236:81–85.
   PubMed Web of Science ®Google Scholar
• Konno H, Taylor LS. (2006). Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci, 95:2692–2705.
   PubMed Web of Science ®Google Scholar
• Kotiyan PN, Vavia PR. (2001). Eudragits: role as crystallization inhibitors in drug-in-adhesive transdermal systems of estradiol. Eur J Pharm Biopharm, 52:173–180.
   PubMed Web of Science ®Google Scholar
• Ma X, Taw J, Chiang CM. (1996) Control of drug crystallization in transdermal matrix system, Int J Pharm 142:115–119.
   Web of Science ®Google Scholar
• Urbanetz NA. (2006). Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000. Eur J Pharm Sci, 28:67–76.
   PubMed Web of Science ®Google Scholar
• Yang J, Grey K, Doney J. (2010). An improved kinetics approach to describe the physical stability of amorphous solid dispersions. Int J Pharm, 384:24–31.
   PubMed Web of Science ®Google Scholar
• Brady JE, Durig T, Shang SS. (2009). Polymer properties and characterization. In: Qiu Y, Chen Y., Zhang GGZ, Liu LPorter WR. (Eds.) Developing Solid Oral Dosage Forms: Pharmaceutical Theory and Practice. 1 ed., New York: Academic Press.
   Google Scholar
• Gustow EE, Ryde TA, Ruddy SB, Jain R, Patel R, Wilkins M, John, & Ryde NP. (2009) Fenofibrate dosage forms. In: Organization, WIP. (Ed.) A61K 9/14(2006.01), A61K 31/216(2006.01) ed.
   Google Scholar
• Jamzad S, Fassihi R. (2006). Role of surfactant and pH on dissolution properties of fenofibrate and glipizide–a technical note. AAPS PharmSciTech, 7:E33.
   PubMed Web of Science ®Google Scholar
• Li X, Gu L, Xu Y, Wang Y. (2009). Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats. Drug Dev Ind Pharm, 35:827–833.
   PubMed Web of Science ®Google Scholar
• Srinarong P, Faber JH, Visser MR, Hinrichs WL, Frijlink HW. (2009). Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants. Eur J Pharm Biopharm, 73:154–161.
   PubMed Web of Science ®Google Scholar
• Shah VP, Tsong Y, Sathe P, Liu JP. (1998). In vitro dissolution profile comparison–statistics and analysis of the similarity factor, f2. Pharm Res, 15:889–896.
   PubMed Web of Science ®Google Scholar
• Kanaujia P, Lau G, Ng WK, Widjaja E, Schreyer M, Hanefeld A et al. (2011). Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy. Drug Dev Ind Pharm, 37:1026–1035.
   PubMed Web of Science ®Google Scholar
• Kaizawa A, Maruoka N, Kawai A, Kamano H, Jozuka T, Senda T, Akiyama T. (2007) Thermophysical and heat transfer properties of phase change material candidate for waste heat transportation system. Heat and Mass Transfer, 44:763–769.
   Web of Science ®Google Scholar
• He H, Yang R, Tang X. (2010). In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion. Drug Dev Ind Pharm, 36:681–687.
   PubMed Web of Science ®Google Scholar
• Mididoddi PK, Repka MA. (2007). Characterization of hot-melt extruded drug delivery systems for onychomycosis. Eur J Pharm Biopharm, 66:95–105.
   PubMed Web of Science ®Google Scholar
• Greenhalgh DJ, Williams AC, Timmins P, York P. (1999). Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci, 88:1182–1190.
   PubMed Web of Science ®Google Scholar
• Friesen DT, Shanker R, Crew M, Smithey DT, Curatolo WJ, Nightingale JA. (2008). Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. Mol Pharm, 5:1003–1019.
   PubMed Web of Science ®Google Scholar
• Alonzo DE, Zhang GG, Zhou D, Gao Y, Taylor LS. (2010). Understanding the behavior of amorphous pharmaceutical systems during dissolution. Pharm Res, 27:608–618.
   PubMed Web of Science ®Google Scholar
• Battu SK, Repka MA, Majumdar S, Madhusudan RY. (2007). Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants. Drug Dev Ind Pharm, 33:1225–1232.
   PubMed Web of Science ®Google Scholar
• Tho I, Liepold B, Rosenberg J, Maegerlein M, Brandl M, Fricker G. (2010). Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media. Eur J Pharm Sci, 40:25–32.
   PubMed Web of Science ®Google Scholar